- The magazine
- Cancer Biology
- Chromatography & Mass Spectrometry
- Contract Research
- Drug Discovery
- Drug Targets
- Flow Cytometry
- Informatics & Lab Automation
- Ingredients, Excipients and Dosages
- Microbiology & Rapid Micro Methods (RMMs)
- Process Analytical Technology (PAT) & Quality by Design (QbD)
- Raman Spectroscopy
- Screening, Assays & High-Content Analysis
- Thermal Processing
- Cell based assays for screening workshop – May 2014
- Biochemical assays for screening workshop – July 2014
- Cell based assays for screening workshop – November 2014
- 3D cell based assays: Advanced workshop – November 2013
- Chemical Biology, Drug Discovery & Screening workshop – October 2013
- Cell based assays for screening workshop – June 2013
- Biochemical Assays Workshop – April 2013
- Biochemical Assays Workshop 2012
- Pharma industry events
- About us
- Contact us
Pharma Industry Reports
European Pharmaceutical Review have partnered with Datamonitor Group to present a series of reports covering every aspect of the pharmaceutical industry.
Biotechnology – Global Industry Profile
The Global Biotechnology market has been growing at a strong rate, generating total revenues of $304 billion in 2012 alone. This trend is expected to continue, fuelled by the need for cleaner, more efficient technology solutions. Pricing and reimbursement have become increasingly contingent on demonstrating economic value to payers. This trend started in Europe and is now spreading across more geographical areas. Meanwhile, emerging markets are being targeted by Life Sciences companies with countries such as China, India and brazil supplementing the mature markets of the U.S. and Europe.
Pfizer Inc: Re-entry to the OTC healthcare market
Pfizer, Inc. was originally founded as fine chemicals business. Following a series of product developments and M&A deals the company is now present in 180 countries around the world, and its portfolio includes human and animal biologic, small molecule medicines, vaccines, nutritional and consumer products.
The “Patent Cliff”: How Pfizer has responded to the loss of its best-selling drug
The global pharmaceuticals market was worth $733bn in 2010. With the patents of many of the world’s best-selling drugs expiring, the market is currently in the middle of a “patent cliff”. This Case Study looks at the various routes companies are taking in order to minimize the adverse effects caused by this “patent cliff”.
OTC Pharmaceuticals: Global Industry Almanac 2011
OTC Pharmaceuticals: Global Industry Almanac is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.
Ultimate go-to guides for reliable insights on the consumer industry…
MarketLine’s Industry Profiles will help you to form a clear picture of individual sectors, including who is operating within them and how they are performing. Concise and accurate, Industry Profiles are presented within the globally recognized Porter’s Five Forces analysis framework to help you understand and apply key insights in minutes.
Johnson & Johnson Case Study: Remicade, a Biotech Blockbuster
Remicade is a drug used in treating a variety of immune system diseases, and its active ingredient is produced through biotechnology. Johnson & Johnson reported Remicade sales of $4.6bn in 2010, and the drug is the best-selling “biologic” in the world. This case study examines its long journey from an academic research laboratory to a leading position in the pharmaceutical market.
Product Insight: Country and Industry Analysis
MarketLine’s Country and Industry Analysis Profiles provide a quick and convenient access point to information on a wide breadth of industries and the countries in which they operate – presenting a holistic overview of individual sectors and their geographic context…
Biotechnology: Global Industry Guide
Biotechnology: Global Industry Guide is an essential resource for top-level data and analysis covering the Biotechnology industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.
Product Insight: Company Profiles
European Pharmaceutical Review in association with Datamonitor Group is pleased to introduce you to our array of company profiles available on our RESEARCH STORE – your one stop to all research needs! Browse and search for the latest merger and acquisition activity, lists of company products and services, and key competitor information for our entire portfolio of companies now…
Pharmaceutical Key Trends 2011: Socio-Demographic and Economic Overview
This report focuses on the socio-demographic and economic trends that are shaping the healthcare industry, and their impact on healthcare payers and the pharmaceutical industry, both directly and indirectly.
United Kingdom: Pharmaceuticals Industry Guide 2011
United Kingdom: Pharmaceuticals Industry Guide is an essential resource for top-level data & analysis covering the United Kingdom Pharmaceuticals industry. It includes data on market size & segmentation, textual analysis of the key trends & competitive landscape. This incisive report provides expert analysis with distinct chapters for Biotechnology, Generics, OTC Pharmaceuticals & Pharmaceuticals.
Case Study: Personalized Cancer Therapy – The era of biomarker identification and companion diagnostic co-development
The treatment of cancer has seen a dramatic shift with the addition of molecular targeted therapies. The mixed and unpredictable responses to these targeted therapies are driving the pharmaceutical industry to search for disease and patient characteristics which confer the best response rates. Identification of biomarkers and companion diagnostics will pave the way for personalized cancer therapy.